Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 101
interventional 70
Observational 29
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 47
Other 8
Drug|placebo 7
Behavioral 2
Biological 2
Behavioral|Drug 1
Device 1
Diagnostic Test 1
Dietary Supplement 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 17
NA 5
Spain 5
Kenya 4
China 3
Egypt 3
France 3
Taiwan 3
Thailand 2
Australia|Brazil|France|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
Australia|Thailand 1
Belgium 1
Cameroon 1
Canada 1
China|Korea, Republic of 1
China|Korea, Republic of|Singapore 1
Gabon 1
Germany|United Kingdom 1
Ghana 1
India 1
Indonesia 1
Israel 1
Japan 1
Moldova, Republic of 1
Netherlands 1
Russian Federation 1
South Africa 1
Switzerland 1
Thailand|Argentina|Brazil|Mexico|Peru|Russian Federation|South Africa 1
United Kingdom 1
United States|Australia|Canada|Germany|Netherlands|New Zealand|Switzerland|United Kingdom 1
United States|Canada|New Zealand|Puerto Rico 1
United States|China|Dominican Republic|France|Greece|Hong Kong|Japan|Korea, Republic of|Malaysia|Puerto Rico|Singapore|Spain|Taiwan|Thailand|Turkey 1
United States|Czechia|France|Germany|Hungary|Poland|Puerto Rico|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 44
2 3
3 2
4 1
6 2
8 3
10 3
11 1
15 3
19 1
28 1
32 1
34 1
41 1
48 2
89 1

Phase

Phase Study_Count
Phase 4 20
N/A 19
Phase 3 15
Phase 2 12
Phase 2/Phase 3 3
Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 26
2 33
3 5
5 1
12 1
NA 4

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 15 30 12.00 32 64.0000 7.00
1st Qu. 36 30 22.75 36 109.0000 24.75
Median 81 30 40.00 40 135.0000 43.50
Mean 1246 30 65.75 130 175.2667 171.15
3rd Qu. 389 30 70.50 179 201.5000 117.00
Max. 9449 30 200.00 318 546.0000 1400.00

Trial Group Type

group_type Group_Count
Experimental 81
Active Comparator 25
Other 8
No Intervention 5
Placebo Comparator 4
NA 4
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 32
Parallel Assignment 31
Crossover Assignment 4
Factorial Assignment 1
Sequential Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 52
Diagnostic 4
Prevention 4
Health Services Research 3
Other 3
Supportive Care 2
Screening 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 8
Ghana 3
Korea, Republic of 2
NA 2
Netherlands 2
Thailand 2
Australia 1
China 1
India 1
India|Malaysia|Thailand 1
Indonesia 1
Japan 1
Mali 1
Switzerland 1
Uganda 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 23
2 2
3 1
8 1
18 1
19 1

Enrollment Metrics

Measure Observational
Min 36.0000
1st Qu 92.0000
Median 219.0000
Mean 908.8966
3rd Qu 497.0000
Max 10000.0000

Observation Model

observational_model Study_Count
Cohort 20
Case-Only 4
NA 2
Case Control 1
Defined Population, Natural History 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 19
Cross-Sectional 6
Longitudinal, Prospective 1
Other 1
Retrospective 1
NA 1

Registries

Studies by Country

Country Study_Count
Portugal|Argentina|Austria|Belarus|Belgium|Bosnia and Herzegovina|Croatia|Czechia|Denmark|Estonia|Finland|France|Georgia|Germany|Greece|Hungary|Iceland|Ireland|Israel|Italy|Latvia|Lithuania|Luxembourg|Netherlands|Norway|Poland|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom 1
Spain 1

Sites per Study

Site_count Study_Count
8 1
110 1

Enrollment Metrics

Measure Registries
Min 446.0
1st Qu 6084.5
Median 11723.0
Mean 11723.0
3rd Qu 17361.5
Max 23000.0

Registry Model

observational_model Study_Count
Cohort 2

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
10 Years 1
30 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03547908 Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults https://ClinicalTrials.gov/show/NCT03547908 Recruiting Gilead Sciences 2021-10-31
NCT03252483 Integrating HIV and Hepatitis C Screening in an Urban Emergency Department https://ClinicalTrials.gov/show/NCT03252483 Completed New York City Health and Hospitals Corporation 2013-05-31
NCT03235349 Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection https://ClinicalTrials.gov/show/NCT03235349 Completed AbbVie 2018-11-15
NCT03222583 A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection https://ClinicalTrials.gov/show/NCT03222583 Completed AbbVie 2018-10-18
NCT03214679 Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID) https://ClinicalTrials.gov/show/NCT03214679 Recruiting Weill Medical College of Cornell University 2021-07-30
NCT03145753 Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) https://ClinicalTrials.gov/show/NCT03145753 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2017-09-30
NCT03126370 Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) https://ClinicalTrials.gov/show/NCT03126370 Completed University of Colorado, Denver 2019-07-12
NCT03115736 TAF for HIV-HBV With Renal Dysfunction https://ClinicalTrials.gov/show/NCT03115736 Completed University Hospital Inselspital, Berne 2019-12-05
NCT03098121 Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection https://ClinicalTrials.gov/show/NCT03098121 Completed Taoyuan General Hospital 2018-11-30
NCT03050905 Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B https://ClinicalTrials.gov/show/NCT03050905 Completed HaEmek Medical Center, Israel 2017-11-16
NCT02938013 deLIVER: Direct Acting Antiviral Effects on the Liver https://ClinicalTrials.gov/show/NCT02938013 Active, not recruiting Johns Hopkins University 2019-09-30
NCT02810275 Folinic Acid: Supplementation and Therapy https://ClinicalTrials.gov/show/NCT02810275 Completed Hospital de Clinicas de Porto Alegre 2013-07-31
NCT02707991 Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection https://ClinicalTrials.gov/show/NCT02707991 Completed Johns Hopkins University 2018-04-30
NCT02625909 Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection. https://ClinicalTrials.gov/show/NCT02625909 Active, not recruiting Kirby Institute 2020-05-30
NCT04405011 NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC https://ClinicalTrials.gov/show/NCT04405011 Recruiting National Taiwan University Hospital 2020-12-28
NCT02613871 Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection https://ClinicalTrials.gov/show/NCT02613871 Completed Gilead Sciences 2017-01-04
NCT02588287 Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir https://ClinicalTrials.gov/show/NCT02588287 Active, not recruiting University of Colorado, Denver 2017-10-31
NCT02555943 DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) https://ClinicalTrials.gov/show/NCT02555943 Recruiting Humanity and Health Research Centre 2020-10-31
NCT02480712 Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection https://ClinicalTrials.gov/show/NCT02480712 Completed Gilead Sciences 2016-04-29
NCT02457611 Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection https://ClinicalTrials.gov/show/NCT02457611 Completed Gilead Sciences 2016-01-31
NCT02414399 Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children https://ClinicalTrials.gov/show/NCT02414399 Completed University of Washington 2020-05-04
NCT02339337 A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection https://ClinicalTrials.gov/show/NCT02339337 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2014-06-30
NCT02339038 Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia https://ClinicalTrials.gov/show/NCT02339038 Completed National Institutes of Health Clinical Center (CC) 2016-06-15
NCT02294136 Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection https://ClinicalTrials.gov/show/NCT02294136 Completed Icahn School of Medicine at Mount Sinai 2017-04-28
NCT02281643 Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana https://ClinicalTrials.gov/show/NCT02281643 Completed Kwame Nkrumah University of Science and Technology 2017-03-15
NCT02233075 REP 2139-Ca / Pegasysâ„¢ Combination Therapy in Hepatitis B / Hepatitis D Co-infection https://ClinicalTrials.gov/show/NCT02233075 Completed Replicor Inc. 2016-11-30
NCT02178592 Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection https://ClinicalTrials.gov/show/NCT02178592 Completed ViiV Healthcare 2017-11-02
NCT02125500 Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection https://ClinicalTrials.gov/show/NCT02125500 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2015-12-31
NCT02103439 An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients https://ClinicalTrials.gov/show/NCT02103439 Completed Biocad 2015-08-26
NCT02073656 Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection https://ClinicalTrials.gov/show/NCT02073656 Completed Gilead Sciences 2014-11-30
NCT01900015 Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection https://ClinicalTrials.gov/show/NCT01900015 Completed Andaluz Health Service 2017-01-17
NCT01805258 Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB https://ClinicalTrials.gov/show/NCT01805258 Completed All India Institute of Medical Sciences, New Delhi 2012-12-31
NCT01751555 Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection https://ClinicalTrials.gov/show/NCT01751555 Completed National Center for AIDS/STD Control and Prevention, China CDC 2013-06-30
NCT01747772 Sonoelastography: Ultrasound Method to Measure Liver Fibrosis https://ClinicalTrials.gov/show/NCT01747772 Completed Massachusetts General Hospital 2014-02-14
NCT01725542 Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders https://ClinicalTrials.gov/show/NCT01725542 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2014-04-30
NCT01718301 HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin https://ClinicalTrials.gov/show/NCT01718301 Completed Fundacion Clinic per a la Recerca Biomédica 2015-03-31
NCT01707472 Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis https://ClinicalTrials.gov/show/NCT01707472 Completed Gilead Sciences 2014-10-17
NCT01557998 Testing and Linkage to Care for Injecting Drug Users in Kenya https://ClinicalTrials.gov/show/NCT01557998 Completed Yale University 2016-04-30
NCT01513941 An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) https://ClinicalTrials.gov/show/NCT01513941 Completed Janssen-Cilag International NV 2014-03-31
NCT01335529 Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin https://ClinicalTrials.gov/show/NCT01335529 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2014-05-31
NCT01327547 A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B https://ClinicalTrials.gov/show/NCT01327547 Completed ViiV Healthcare 2013-04-23
NCT04382092 Co-infection Management in COVID-19 Critically Ill https://ClinicalTrials.gov/show/NCT04382092 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2020-04-24
NCT04325438 The Impact of Pharmacists’ Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia https://ClinicalTrials.gov/show/NCT04325438 Completed Bekasi City Public Hospital 2019-02-28
NCT04264130 Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection https://ClinicalTrials.gov/show/NCT04264130 Completed Centre de Recherche Médicale de Lambaréné 2019-12-31
NCT04032860 RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection https://ClinicalTrials.gov/show/NCT04032860 Recruiting West China Hospital 2023-02-10
NCT03797014 B/F/TAF Switch Study for HIV-HBV Coinfection https://ClinicalTrials.gov/show/NCT03797014 Recruiting University of Maryland, Baltimore 2021-02-28
NCT03711721 Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa https://ClinicalTrials.gov/show/NCT03711721 Completed University of Washington 2017-08-31
NCT03646396 Effect of Sofosbuvir-daclatasuvir on Angiogenesis https://ClinicalTrials.gov/show/NCT03646396 Recruiting Tanta University 2025-08-31
NCT03549832 Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure https://ClinicalTrials.gov/show/NCT03549832 Completed Assiut University 2019-01-30
NCT03549312 Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy https://ClinicalTrials.gov/show/NCT03549312 Recruiting Saskatchewan Health Authority - Regina Area 2020-07-21
NCT03499639 Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease https://ClinicalTrials.gov/show/NCT03499639 Completed Assiut University 2018-08-01
NCT01222611 HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir https://ClinicalTrials.gov/show/NCT01222611 Completed Fundacion SEIMC-GESIDA 2013-06-30
NCT01064947 Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis https://ClinicalTrials.gov/show/NCT01064947 Completed Derm Research, PLLC 2012-01-31
NCT00959166 To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection https://ClinicalTrials.gov/show/NCT00959166 Completed Imperial College London 2011-06-30
NCT00879047 Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection https://ClinicalTrials.gov/show/NCT00879047 Completed University of California, San Francisco 2013-04-30
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r https://ClinicalTrials.gov/show/NCT00866021 Completed Fundacion SEIMC-GESIDA 2012-06-30
NCT00845676 Treatment of Acute Hepatitis C Virus in HIV Co-Infection https://ClinicalTrials.gov/show/NCT00845676 Completed University of California, San Francisco 2010-12-31
NCT03731559 Efficacy, Safety and Pharmacokinetics of DTG With RIF https://ClinicalTrials.gov/show/NCT03731559 Recruiting The HIV Netherlands Australia Thailand Research Collaboration 2021-06-30
NCT01939197 A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection https://ClinicalTrials.gov/show/NCT01939197 Completed AbbVie 2016-07-21
NCT02129244 A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes https://ClinicalTrials.gov/show/NCT02129244 Active, not recruiting Johns Hopkins University 2021-12-31
NCT00686790 Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) https://ClinicalTrials.gov/show/NCT00686790 Completed Merck Sharp & Dohme Corp. 2009-05-31
NCT00665353 Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance https://ClinicalTrials.gov/show/NCT00665353 Completed AIDS Clinical Trials Group 2011-05-31
NCT00507221 Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression https://ClinicalTrials.gov/show/NCT00507221 Completed University of Washington 2011-07-31
NCT00476463 Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection https://ClinicalTrials.gov/show/NCT00476463 Completed The HIV Netherlands Australia Thailand Research Collaboration 2008-12-31
NCT00360464 A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases https://ClinicalTrials.gov/show/NCT00360464 Completed Pfizer 2007-06-30
NCT00209313 Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon https://ClinicalTrials.gov/show/NCT00209313 Completed Fred Hutchinson Cancer Research Center NA
NCT00192595 Tenofovir in HIV/HBV Coinfection https://ClinicalTrials.gov/show/NCT00192595 Completed Kirby Institute 2007-01-31
NCT00130910 Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation https://ClinicalTrials.gov/show/NCT00130910 Completed University of Washington NA
NCT00127959 Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection https://ClinicalTrials.gov/show/NCT00127959 Completed International Antiviral Therapy Evaluation Center NA
NCT00015652 Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection https://ClinicalTrials.gov/show/NCT00015652 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02964767 HIV-Tb Confections Among HIV Patients https://ClinicalTrials.gov/show/NCT02964767 Completed Singh, Ranjan Kumar, M.D. 2016-05-31
NCT01350648 Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection https://ClinicalTrials.gov/show/NCT01350648 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02505243 Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens https://ClinicalTrials.gov/show/NCT02505243 Completed Radboud University 2016-06-30
NCT02427360 Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers https://ClinicalTrials.gov/show/NCT02427360 Completed University of Oxford 2015-12-31
NCT02427204 Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality https://ClinicalTrials.gov/show/NCT02427204 Completed Icahn School of Medicine at Mount Sinai 2018-01-18
NCT02325102 Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric Department https://ClinicalTrials.gov/show/NCT02325102 Completed Hillel Yaffe Medical Center 2014-09-30
NCT02109887 Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP) https://ClinicalTrials.gov/show/NCT02109887 Completed Asan Medical Center 2015-12-31
NCT02102451 Control and Elimination Within Australia of Hepatitis C From People Living With HIV https://ClinicalTrials.gov/show/NCT02102451 Active, not recruiting Kirby Institute 2020-12-31
NCT01296529 Study on Immunopathogenesis in HIV and Hepatitis C Coinfection https://ClinicalTrials.gov/show/NCT01296529 Completed Rush University Medical Center 2011-12-31
NCT01924455 HBV-HIV Coinfection Research Network https://ClinicalTrials.gov/show/NCT01924455 Completed Virginia Commonwealth University 2019-03-31
NCT01714076 Co-infections in Children Hospitalised for Bronchiolitis https://ClinicalTrials.gov/show/NCT01714076 Completed Princess Amalia Children’s Clinic 2015-05-31
NCT01690533 Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease https://ClinicalTrials.gov/show/NCT01690533 Completed Bayer 2010-12-14
NCT01611402 Gene Expression in HIV and Tuberculosis Co-infection https://ClinicalTrials.gov/show/NCT01611402 Completed National Institutes of Health Clinical Center (CC) NA
NCT01423643 HCV/HIV Coinfection: Antiviral Therapy and Fibrosis https://ClinicalTrials.gov/show/NCT01423643 Completed Johns Hopkins University 2015-10-31
NCT01335230 The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients https://ClinicalTrials.gov/show/NCT01335230 Completed University of Cincinnati 2013-01-31
NCT04410263 Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches https://ClinicalTrials.gov/show/NCT04410263 Recruiting University of Zurich 2023-12-30
NCT03800407 Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection https://ClinicalTrials.gov/show/NCT03800407 Recruiting University of Florida 2023-01-31
NCT03800394 Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents https://ClinicalTrials.gov/show/NCT03800394 Recruiting University of Florida 2022-08-31
NCT03800381 Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet https://ClinicalTrials.gov/show/NCT03800381 Recruiting University of Florida 2022-08-30
NCT03663920 HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia https://ClinicalTrials.gov/show/NCT03663920 Recruiting Ina-Respond 2023-12-31
NCT03645044 Towards a Functional Cure for HBV - The COMMIT Cohort Study https://ClinicalTrials.gov/show/NCT03645044 Recruiting University of Melbourne 2021-06-30
NCT04048850 Zepatier in Patients With Substance Use https://ClinicalTrials.gov/show/NCT04048850 Enrolling by invitation University of Illinois at Chicago 2020-08-01
NCT03508115 Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents https://ClinicalTrials.gov/show/NCT03508115 Completed Corporacion Parc Tauli 2017-09-06
NCT00782158 Hepatitis B and HIV Co-Infection in Patients in Uganda https://ClinicalTrials.gov/show/NCT00782158 Completed National Institutes of Health Clinical Center (CC) NA
NCT00575315 HIV-HCV Coinfection: Impact of Immune Dysfunction https://ClinicalTrials.gov/show/NCT00575315 Completed Virginia Commonwealth University 2014-08-31
NCT00567151 Co-Infection of NTM in Patients With Smear Positive Pulmonary TB https://ClinicalTrials.gov/show/NCT00567151 Completed Seoul National University Hospital 2008-12-31
NCT00476723 HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection https://ClinicalTrials.gov/show/NCT00476723 Completed The HIV Netherlands Australia Thailand Research Collaboration 2007-12-31
NCT00471666 Medical Implications of Coinfection With Malaria and Filariasis Parasites https://ClinicalTrials.gov/show/NCT00471666 Completed National Institutes of Health Clinical Center (CC) NA
NCT00361179 Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT00361179 Completed National Taiwan University Hospital NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02699736 EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV https://ClinicalTrials.gov/show/NCT02699736 Enrolling by invitation Rigshospitalet, Denmark 2030-12-31
NCT02693847 Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients https://ClinicalTrials.gov/show/NCT02693847 Recruiting Hospital Universitario de Valme 2020-12-31